Results 161 to 170 of about 1,971,842 (244)
Immune‐related adverse events with mogamulizumab in cutaneous T‐cell lymphoma: A multicentre study
In a nationwide multicentre study of 403 patients with cutaneous T‐cell lymphoma treated with mogamulizumab, non‐MAR immune‐related adverse events were reported in 8.4% of patients across responding centres. These events were diverse, sometimes severe or persistent, and could occur late during mogamulizumab treatment.
David Neubauer +28 more
wiley +1 more source
Oral Site-Specific Patch Testing Directly at the Fixed Drug Eruption Site in Drug Allergy Investigation. [PDF]
Chumsaengchotsakul C +3 more
europepmc +1 more source
Pharmacogenomic‐guided managment of behavioral symptoms within the 4Ms framework.
Gianna Franco +3 more
wiley +1 more source
A Rare Case of Leprosy in Sweden Mimicking Drug Eruption. [PDF]
Alvergren G +3 more
europepmc +1 more source
A Successful Outcome of Upadacitinib Therapy in a Patient with Genital Erosive Fixed Drug Eruption: A Case Report. [PDF]
Li C +7 more
europepmc +1 more source
This systematic review evaluated the effectiveness of orofacial myofunctional therapy (OMT) for improving feeding and swallowing outcomes in children aged 4–12 years. Searches of four databases identified 17 studies, all reporting positive feeding and/or swallowing outcomes, including improved eating and swallowing skills, orofacial muscle function and
Danielle Carey +6 more
wiley +1 more source
CHARGE Syndrome: A Narrative Review and Update on Diagnosis, Assessment and Management
ABSTRACT Background CHARGE syndrome (CS) is a rare multisystemic genetic condition caused by a pathogenic variant in the DNA‐binding protein‐7 CHD7 gene. The condition affects the development of neural crest cells, which give rise to craniofacial structures, cranial nerves, ears, eyes and the heart, resulting in diverse and complex clinical features ...
Eleni M. van Gelder +7 more
wiley +1 more source
Bullous fixed drug eruption associated with ibuprofen. [PDF]
Wen HY, Gao XH.
europepmc +1 more source
Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa +5 more
wiley +1 more source
Psoriasiform Drug Eruption following Fremanezumab: A Case Report. [PDF]
Coffman K +4 more
europepmc +1 more source

